Joseph M. Zubretsky
President & CEO at Molina Healthcare Inc
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Molina Healthcare Inc, 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 1, 2026 | Molina Healthcare Inc | Shares withheld for tax | โ8,597 | $154.05 | $1,324,368 |
| Mar 1, 2026 | Molina Healthcare Inc | Grant or award | +66,417 | $145.75 | $9,680,278 |
| Apr 30, 2025 | Molina Healthcare Inc | Open-market sale | โ86,400 | $320.00 | $27,648,000 |
| Apr 30, 2025 | Molina Healthcare Inc | Open-market sale | โ1,100 | $324.70 | $357,170 |
| Mar 1, 2025 | Molina Healthcare Inc | Grant or award | +42,996 | $301.12 | $12,946,956 |
| Mar 1, 2025 | Molina Healthcare Inc | Shares withheld for tax | โ19,993 | $301.12 | $6,020,292 |
| Mar 1, 2025 | Molina Healthcare Inc | Shares withheld for tax | โ9,036 | $301.12 | $2,720,920 |
| Mar 1, 2025 | Molina Healthcare Inc | Grant or award | +22,491 | $288.12 | $6,480,107 |
| Mar 1, 2024 | Molina Healthcare Inc | Grant or award | +68,844 | $387.21 | $26,657,085 |
| Mar 1, 2024 | Molina Healthcare Inc | Shares withheld for tax | โ32,069 | $387.21 | $12,417,437 |
| Mar 1, 2024 | Molina Healthcare Inc | Shares withheld for tax | โ27,374 | $387.21 | $10,599,487 |
| Mar 1, 2024 | Molina Healthcare Inc | Grant or award | +16,735 | $387.21 | $6,479,959 |
| Nov 21, 2023 | Molina Healthcare Inc | Gift | โ5,700 | โ | โ |
| Mar 1, 2023 | Molina Healthcare Inc | Shares withheld for tax | โ14,211 | $273.80 | $3,890,972 |
| Mar 1, 2023 | Molina Healthcare Inc | Grant or award | +22,644 | $273.08 | $6,183,624 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.